Applied Materials, Inc.
Intrinsic value range 59.72 – 136.85 USD · margin of safety 33%. BUY ≤ buy-below · WATCH ≤ mid-based buy price · HOLD/FAIR ≤ mid value · OVERVALUED above mid.
Defensive: 5 of 7 pass · Enterprising: 5 of 6 pass
What to look at
- How far from a Graham buy?
The price would have to fall 87% to reach the buy-below price (40.01 USD), and 77% to reach Graham's mid value (70.00 USD).
Healthy companies rarely fall that far. For a Graham investor this is a pass, not a wait.
- What growth does the price assume?
Today's price only makes sense if earnings grow 13.5% a year for 10 years (and you want a 9% yearly return).
That is slower than its past growth (18.5%/yr): the market expects a slowdown, which leaves some room if growth holds up.
Reverse DCF details ↓ - Is it a great business? (quality lens, not Graham)
5 of 5 quality checks pass.
Its free-cash-flow value is 235.84 USD; the price is 1.3× that.
The price matches that value if free cash flow would grow 13.3% a year (past: 16.6%/yr).
Quality details ↓ - How each approach reads this
Graham investor: not a buy at this price. Look for cheaper companies (see the starter list in the README).
Quality investor: a strong business; only interesting if you believe free cash flow can grow 13.3%/yr or better for 10 years.
Data completeness
| Series | Years | Span |
|---|---|---|
| Revenue | 10 of 10 | 2016–2025 |
| Net income | 10 of 10 | 2016–2025 |
| EPS (diluted) | 10 of 10 | 2016–2025 |
| Dividends per share | 10 of 10 | 2016–2025 |
| Book value per share | 10 of 10 | 2016–2025 |
| Current assets | 10 of 10 | 2016–2025 |
| Current liabilities | 10 of 10 | 2016–2025 |
| Long-term debt | 10 of 10 | 2016–2025 |
| Intangibles | 10 of 10 | 2016–2025 |
| Operating cash flow | 10 of 10 | 2016–2025 |
| Capital expenditure | 10 of 10 | 2016–2025 |
Annual figures
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.82B | 14.70B | 16.70B | 14.61B | 17.20B | 23.06B | 25.79B | 26.52B | 27.18B | 28.37B |
| Net income | 1.72B | 3.52B | 3.04B | 2.71B | 3.62B | 5.89B | 6.53B | 6.86B | 7.18B | 7.00B |
| EPS (diluted) | 1.54 | 3.25 | 2.96 | 2.86 | 3.92 | 6.40 | 7.44 | 8.11 | 8.61 | 8.66 |
| Dividend / share | 0.10 | 0.10 | 0.70 | 0.83 | 0.87 | 0.94 | 1.02 | 1.22 | 1.52 | 1.78 |
| Book value / share | 6.88 | 9.08 | 7.08 | 8.97 | 11.57 | 13.73 | 14.45 | 19.63 | 23.23 | 25.74 |
| Current assets | 8.35B | 12.92B | 10.60B | 10.21B | 13.37B | 16.11B | 15.93B | 19.15B | 21.22B | 20.88B |
| Current liabilities | 3.63B | 4.12B | 3.92B | 4.45B | 4.46B | 6.34B | 7.38B | 7.37B | 8.47B | 8.00B |
| Long-term debt | 3.12B | 5.30B | 5.31B | 4.71B | 5.45B | 5.45B | 5.46B | 5.46B | 5.46B | 6.46B |
| Total equity | 7.41B | 9.63B | 6.84B | 8.21B | 10.58B | 12.25B | 12.19B | 16.35B | 19.00B | 20.41B |
| Shares | 1.08B | 1.06B | 967.00M | 916.00M | 914.00M | 892.00M | 844.00M | 833.00M | 818.00M | 793.00M |
| Intangibles | 3.89B | 3.78B | 3.58B | 3.56B | 3.62B | 3.58B | 4.04B | 4.03B | 3.98B | 3.93B |
| Operating cash flow | 2.57B | 3.79B | 3.79B | 3.25B | 3.80B | 5.44B | 5.40B | 8.70B | 8.68B | 7.96B |
| Capital expenditure | 253.00M | 345.00M | 622.00M | 441.00M | 422.00M | 668.00M | 787.00M | 1.11B | 1.19B | 2.26B |
| Free cash flow | 2.31B | 3.44B | 3.17B | 2.81B | 3.38B | 4.77B | 4.61B | 7.59B | 7.49B | 5.70B |
Defensive investor criteria (ch. 14)
- Adequate size PASS Revenue ≥ 2.00B USD 28.37B USD (2025)
- Strong financial condition PASS Current ratio ≥ 2 and long-term debt ≤ net current assets Current ratio 2.61; NCA 12.88B USD; LT debt 6.46B USD FY2025.
- Earnings stability PASS Positive earnings in each of the last 10 years 10 of 10 years positive
- Dividend record PASS Uninterrupted dividends for 20 years 21 consecutive years with dividends (to 2025)
- Earnings growth PASS 3-yr avg EPS at end ≥ 1.33 × 3-yr avg EPS at start of 10 years 3-yr avg 2016–2018: 2.58 → 2023–2025: 8.46 (+227%)
- Moderate P/E FAIL Price ≤ 15 × 3-yr avg EPS P/E 35.8 (price 302.63 / avg EPS 8.46)
- Moderate P/B FAIL P/B ≤ 1.5, or P/E × P/B ≤ 22.5 P/B 11.76 (BVPS 25.74, FY2025); P/E × P/B 420.5
Enterprising investor criteria (ch. 15)
- Current ratio PASS Current ratio ≥ 1.5 2.61 (FY2025)
- Debt vs net current assets PASS Long-term debt ≤ 1.1 × net current assets LT debt 6.46B USD vs 1.1 × NCA 14.17B USD FY2025.
- Earnings stability PASS No deficit in the last 5 years 5 of 5 years positive
- Current dividend PASS Some current dividend 1.78 USD (FY2025)
- Earnings growth PASS Latest EPS > EPS 5 years earlier 8.66 (2025) vs 3.92 (2020)
- Price vs net tangible assets FAIL Price ≤ 1.2 × net tangible assets per share Price 302.63 vs 1.2 × NTA/share 24.94 (FY2025)
Valuation (mechanical)
- 3-yr avg EPS
- 8.46
- EPS years
- 2023–2025
- Book value / share
- 25.74
- 3-yr avg EPS
- 8.46
- g (%)
- 7.00
- Y = AAA yield (%)
- 6.12
- Normalised EPS
- 5.38
- EPS years
- 2016–2025
- Discount rate (%)
- 9.00
| Range | Low | Mid | High |
|---|---|---|---|
| Intrinsic value | 59.72 | 70.00 | 136.85 |
| × (1 − 0.33) | 40.01 | 46.90 |
- g = historical EPS growth 18.5%/yr (3-yr avg EPS 2.58 (2016–2018) → 8.46 (2023–2025) over 7 yrs), clamped to 0–7% → 7.0%.
Reverse DCF: what growth does the price assume?
A reverse DCF turns the question around: instead of estimating value from assumed growth, it takes today's price and solves for the yearly earnings growth that would justify it, if you want a 9% yearly return.
- Price
- 302.63
- Latest EPS
- 8.66
- Discount rate (%)
- 9.00
- Terminal multiple
- 15.00
The market price assumes EPS grows 13.5% a year for 10 years, more than the 7.0% used above. Not part of the value range.
Sensitivity
Mid value (buy-below underneath) for growth g ±2 pp and rates ±1 pp. The rate shift moves both the EPV discount rate and the AAA yield Y.
| g \ r | 8% | 9% | 10% |
|---|---|---|---|
| 5.0% | 70.0045.02 | 70.0040.01 | 70.0036.01 |
| 7.0% | 70.0045.02 | 70.0040.01 | 70.0036.01 |
| 9.0% | 70.0045.02 | 70.0040.01 | 70.0036.01 |
AI assumptions vs mechanical
| Mechanical | AI-adjusted | |
|---|---|---|
| Growth g | 7.0% | 4.0% |
| EPS adjustments | none | 0 |
| Cyclical treatment | no | yes |
| Graham number | 70.00 | 70.00 |
| Graham revised formula | 136.85 | 63.76 |
| Earnings power value | 59.72 | 59.72 |
| Range low – high | 59.72 – 136.85 | 59.72 – 70.00 |
| Buy below | 40.01 | 40.01 |
| Verdict | OVERVALUED | OVERVALUED |
The headline uses the lower buy-below price (mechanical).
Growth rate: 4.0%
EPS rose from 1.54 in 2016 to 8.66 in 2025, but the 3-yr average of 2.58 (2016–2018) to 8.46 (2023–2025) came from a cyclical upswing and cannot be projected forward. The last three years show flattening: 8.11 (2023), 8.61 (2024), 8.66 (2025), and 2025 net income of 6.998B fell from 7.177B in 2024. A conservative rate well below the 7% cap is therefore appropriate.
Cyclical: yes
EPS fell from 3.25 (2017) to 2.96 (2018) and 2.86 (2019), then jumped to 6.40 (2021). Revenue fell from 16.71B (2018) to 14.61B (2019), which is typical of semiconductor equipment spending cycles.
AI-adjusted valuation details
- 3-yr avg EPS
- 8.46
- EPS years
- 2023–2025
- Book value / share
- 25.74
- normalised EPS (cyclical)
- 5.38
- g (%)
- 4.00
- Y = AAA yield (%)
- 6.12
- Normalised EPS
- 5.38
- EPS years
- 2016–2025
- Discount rate (%)
- 9.00
Quality at a fair price (not Graham)
Graham's tests favour cheap, asset-heavy companies, so strong asset-light businesses almost always fail them. This section takes a different view: is it a high-quality business, and what is it worth on its free cash flow? It is not used in the verdict above.
- Return on equity PASS Average ROE ≥ 15% 39% average over 10 years
- Cash conversion PASS Free cash flow ≥ 80% of net income (all years combined) 94% (45.27B USD FCF vs 48.05B USD net income, 10 yrs)
- Consistent free cash flow PASS Positive free cash flow every year 10 of 10 years positive
- Debt payback PASS Long-term debt ≤ 4 years of free cash flow 0.9 years (6.46B USD debt / 6.93B USD avg FCF)
- Free cash flow growth PASS FCF per share growth ≥ 3%/yr 16.6%/yr (3-yr avg FCF/share 2.89 (2016–2018) → 8.48 (2023–2025) over 7 yrs)
Free-cash-flow value
- FCF per share (avg 2023–2025)
- 8.48
- Growth g (10 yrs)
- 10.0%
- Discount rate
- 9.0%
- Terminal growth
- 2.5%
- Price
- 302.63
- Growth implied by price
- 13.3%
Historical FCF/share growth 16.6%/yr, bounded to 0–10%.
What if growth is…
| FCF growth, next 10 yrs | Value / share | vs price |
|---|---|---|
| 0% / yr | 110.97 | -63% |
| 5% / yr | 161.54 | -47% |
| 10% / yr | 235.84 | -22% |
| 15% / yr | 343.93 | +14% |
Pick the growth you find realistic. If its value is well above the price, the price leaves room for error at that growth.
Free cash flow per share by year
| 2016 | 2.15 |
| 2017 | 3.25 |
| 2018 | 3.27 |
| 2019 | 3.06 |
| 2020 | 3.70 |
| 2021 | 5.35 |
| 2022 | 5.46 |
| 2023 | 9.12 |
| 2024 | 9.15 |
| 2025 | 7.19 |
Analysis
The business
Applied Materials is a US semiconductor equipment company. It sells the machines and related materials that chipmakers use to build chips and displays, and it earns additional revenue from servicing that installed equipment. Revenue was 28.37B USD in 2025 and net income was 7.00B USD. Demand depends on how much chipmakers decide to spend on new capacity.
Durable competitive advantages
The input contains no market-share data, so this rests on the financial record. The company has earned an average return on equity of 39% over ten years and has generated positive free cash flow every year. Those results suggest strong technology, high switching costs and a sticky service base, though that interpretation goes beyond the numbers given. The cash-flow results come from a separate quality lens, which is not part of Graham's verdict.
Key risks
The business is cyclical. EPS slipped from 3.25 in 2017 to 2.96 in 2018 and 2.86 in 2019, and revenue fell from 16.71B USD in 2018 to 14.61B USD in 2019. Recent growth has also flattened: net income was 6.998B USD in 2025 against 7.177B USD in 2024, and capital spending rose to 2.26B USD in 2025. The biggest risk to the valuation is price. At 302.63 USD the shares trade at a P/E of 35.8 and a P/B of 11.76, and the market-implied growth of 13.46% is well above what the cyclical record supports.
Bull case
Earnings per share rose from 1.54 in 2016 to 8.66 in 2025, the balance sheet is strong, and the dividend has grown to 1.78 USD per share. If chip investment stays strong, the company could keep compounding. The separate quality lens, which is not Graham, puts a cash-flow value of 235.84 USD per share at 10% growth, with free cash flow per share of 7.19 in 2025.
Bear case
Earnings have recently stalled, and the semiconductor cycle could turn down again. Graham-style estimates sit far below the market price: 70.00 USD for the Graham number, 59.72 USD for earnings power value, and a revised-formula value of 136.85 USD (mechanical) or 63.76 USD (AI-adjusted). The buy-below level is 40.01 USD. A cyclical downturn combined with a high multiple could mean a large loss of capital.
Why it passes or fails Graham's tests
The company passes five of the seven defensive tests. It clears size (revenue 28.37B USD), financial condition (current ratio 2.61, and long-term debt of 6.46B USD against net current assets of 12.88B USD), earnings stability (10 of 10 years positive), dividend record (21 consecutive years) and earnings growth (3-year average EPS up from 2.58 to 8.46). It fails the two price tests. The P/E of 35.8 is far above the limit of 15 times average earnings. The P/B of 11.76 and a P/E × P/B of 420.5 are far above the 22.5 ceiling.
For the enterprising investor, it passes the current ratio (2.61), the debt test against net current assets, five years without a loss, a current dividend of 1.78 USD, and EPS growth (8.66 versus 3.92 five years earlier). It fails the price versus net tangible assets test: the price of 302.63 USD is far above 1.2 times net tangible assets per share of 24.94. Overall, the company is financially sound and profitable by Graham's standards but is priced well beyond his valuation limits, so the verdict is OVERVALUED.
Written by an AI model from the figures above. Every number in this text was checked against the computed data.
What the market thinks
| Consensus rating | strong buy (1.5 on 1–5, 1 = strong buy) |
| Mean price target | 557.86 USD |
| Analysts | 36 |
Shown for context only. Analyst opinions are not used in the valuation or the verdict.
Sources and timestamps
Financial statements
- Revenue
- SEC XBRLRevenue
From Revenues 2016–2019Contract With Customer Excluding Assessed Tax 2020–2025 - Net income
- SEC XBRLNet
Income Loss 2016–2025 - EPS (diluted)
- SEC XBRLEarnings
Per Share Diluted 2016–2025 - Dividend / share
- SEC XBRLCommon
Stock Dividends Per Share Declared 2016–2025 - Total equity
- SEC XBRLStockholders
Equity 2016–2025 - Current assets
- SEC XBRLAssets
Current 2016–2025 - Current liabilities
- SEC XBRLLiabilities
Current 2016–2025 - Long-term debt
- SEC XBRLLong
Term Debt Noncurrent 2016–2025 - Operating cash flow
- SEC XBRLNet
Cash Provided By Used In Operating Activities 2016–2025 - Capital expenditure
- SEC XBRLPayments
To Acquire Property Plant And Equipment 2016–2025 - Shares
- SEC XBRLCommon
Stock Shares Outstanding 2016–2025 - Intangibles
- SEC XBRLGoodwill + Intangible
Assets Net Excluding Goodwill 2016–2025 - Book value / share
- derivedtotal_equity / shares_outstanding
Market data and this run
- Price
- 302.63 USD · yfinance2026-11-21 15:25 UTC
- AAA yield (Y)
- 6.12%FRED AAA (Moody's Seasoned Aaa Corporate Bond Yield), 2026-10-01
- Dividend history
- yfinance dividend history (calendar-year totals, split-adjusted)coverage from 1984
- Analyst consensus
- yfinance (analyst consensus)
- Generated
- 2026-11-21 15:25 UTC
- AI usage
- anthropic/claude-sonnet-5.52 calls · 11,414 in / 1,939 out tokens · $0.0422
Not financial advice. This report is generated automatically from public data for personal research. Data can be incomplete or wrong; figures are not audited. It gives signals only and never trades. Check the filings before making any decision.